|
Correlation between NDRG1 gene polymorphism and neuropathy (N) in metastatic breast cancer (MBC) patients (pts) enrolled in the PAINTER study (Polymorphism And INcidence of Toxicity in ERibulin treatment). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; Eisai; Novartis; Pfizer |
Consulting or Advisory Role - Amgen; Celgene; Eisai; Pfizer |
Research Funding - Eisai (Inst); Eisai (Inst) |
Travel, Accommodations, Expenses - Celgene; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Cascadian Therapeutics; Lilly; Novartis; Odonate Therapeutics; Roche |
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Alessandro Stefano Bertolini |
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Merck |
Travel, Accommodations, Expenses - Celgene; Ipsen; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Istituto Gentili |
|
|
Research Funding - Eisai (Inst) |